Related Experiment Video
Updated: Aug 2, 2025

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
Published on: April 16, 2019
Intermittent fasting-the future treatment in NASH patients?
Iulia Minciuna1,2, Suchira Gallage3,4, Mathias Heikenwalder4,3
1Regional Institute of Gastroenterology and Hepatology Octavian Fodor, Cluj-Napoca, Romania.
Intermittent fasting shows promise for treating non-alcoholic steatohepatitis (NASH), a major cause of chronic liver disease. This approach may improve metabolic health and reduce liver disease progression by targeting key NASH drivers.
Area of Science:
- Hepatology and Metabolic Diseases
- Gastroenterology
Background:
- Non-alcoholic steatohepatitis (NASH) is a leading cause of chronic liver disease, potentially progressing to end-stage liver disease and hepatocellular carcinoma (HCC).
- NASH significantly burdens healthcare systems, including non-cirrhotic patients, and is an increasing indication for liver transplantation.
Approach:
- This review explores the metabolic drivers of NASH pathogenesis.
- It examines how intermittent fasting (IF) interventions can target these drivers.
- The review summarizes current clinical evidence on IF for NASH management.
Key Points:
- Intermittent fasting aids weight loss and improves cardiometabolic parameters like blood pressure, lipids, and glucose metabolism.
- IF reduces key NASH-related cellular stressors including inflammation, endoplasmic reticulum stress, and oxidative stress.
- Intermittent fasting also modulates gut microbiota and improves endothelial function.
Conclusions:
- Intermittent fasting presents a promising therapeutic strategy for NASH by addressing its core metabolic and inflammatory pathways.
- Further clinical research is warranted to fully establish the efficacy of intermittent fasting in improving NASH prognosis.
Related Concept Videos
Metabolic States of the Body: Fasting and Starvation
Chronic Pancreatitis II: Collaborative Care
Assessment:
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Metabolic States of the Body: The Postabsorptive State
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...

